Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Navigation/Suche
- Forscher*innen
- Institutionen
- Projekte
- Publikationen
- Partner
- Geldgeber
- Ausstattung
- Knowhow
- Forschungsfelder
"Köpfe" der aktuellen Meldungen:
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Siekmeier, R; Grammer, TB; Scharnagl, H; Stojakovic, T; König, W; März, W.
Lipoprotein-assoziierte Phospholipase A2: ein neuer Marker für kardiovaskuläre Erkrankungen.
LaboratoriumsMedizin / Journal of Laboratory Medicine. 2010; 34(4): 217-222.
Doi: 10.1515/JLM.2010.040
Web of Science
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- März Winfried
- Scharnagl Hubert
- Stojakovic Tatjana
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Research completed during recent years has led to the notion that atherosclerosis is an inflammatory disease. Consequently, highly sensitive assays for C-reactive protein have been used to obtain additional information regarding an individual's cardiovascular risk. However, the measurement of lipoprotein-associated phospholipase A(2), which specifically reflects the stability of the atherosclerotic plaque, the pathological correlate of atherosclerosis, has not yet been widely used.
- Find related publications in this database (Keywords)
- atherosclerosis
- lipoprotein-associated phospholipase A2 (Lp-PLA2)
- myocardial infarction